Obstruction of St Jude Medical valves in the aortic position  by Teshima, Hideki et al.
Letters to the Editor4. Le´gare´ JF, Ross DB, Issekutz TB, Ruigrok
W, Creaser K, Hirsch GM, et al. Prevention
of allograft heart valve failure in a rat
model. J Thorac Cardiovasc Surg. 2001;
122:310-7.
5. Le´gare´ JF, Lee TD, Creaser K, Ross DB. T
lymphocytes mediate leaflet destruction and
allograft aortic valve failure in rats. Ann Tho-
rac Surg. 2000;70:1238-45.
6. Cebotari S, Mertsching H, Kallenbach K, Ko-
stin S, Repin O, Batrinac A, et al. Construc-
tion of autologous human heart valves based
on an acellular allograft matrix. Circulation.
2002;106(12 Suppl 1):I63-8.
doi:10.1016/S0022-5223(03)00597-X
Obstruction of St Jude Medical
valves in the aortic position
To the Editor:
I enjoyed the recent article by Teshima and
coworkers, “Obstruction of St Jude Medi-
cal Valves in the Aortic Position: Histology
and Immunohistochemistry of Pannus”
(J Thorac Cardiovasc Surg. 2003;126:401-
7). I recently reoperated on 2 young female
patients with dysfunction of St Jude Med-
ical prosthetic valves (St Jude Medical, Inc,
St Paul, Minn) in the aortic position. Both
patients had moderate amounts of pannus
formation on the valve. Both patients had
significant periods during their postopera-
tive management when anticoagulation
was discontinued or inadequate. Perhaps
more significantly, they had small aortic
roots. The explanted St Jude Medical
valves were 19 mm in both patients.
Are young female patients who receive
19- or 21-mm implants for small aortic
roots predisposed toward pannus forma-
tion? Is pannus formation detected only in
19- and 21-mm valves, in which a minor
reduction in orifice area may result in clin-
ically apparent hemodynamic deteriora-
tion? I noticed the female predilection in
the published series and wondered about
the size of the explanted prostheses and if
the postimplantation coagulation history of
these patients was known.
Frank A. Baciewicz, Jr, MD





Reply to the Editor:
We read with interest the letter by Dr Ba-
ciewicz regarding his experience of two
Thyoung female patients with prosthetic valve
dysfunction as a result of pannus forma-
tion. In our study, we showed histologic
and immunohistochemical findings of pan-
nus tissue that caused prosthetic valve dys-
function after aortic valve replacement. We
believe that our study provides information
useful to elucidate the mechanisms of pan-
nus formation in patients receiving pros-
thetic valves. We also think, however, that
our findings are not sufficient to reach con-
clusion regarding the complete pathoge-
netic mechanisms of this disorder, and fur-
ther prospective studies including more
patients and control specimens are re-
quired.
The sizes of the prosthesis explanted in
this study were 21 mm in 6 patients (all
female), 23 mm in 2 (1 male and 1 female),
25 mm in 1 (male), and 27 mm in 1 (male).
The ratio of effective orifice area (accord-
ing to the manufacturer’s report) to body
surface area, as an index of patient-pros-
thesis mismatch, in our patients with pan-
nus receiving 21-mm prostheses was 1.0 
0.1 cm2. The ratio was slightly lower than
that in patients with normally functioning
21-mm aortic prostheses (1.2  0.2 cm2).1
Because remaining significant transvalvu-
lar gradient after valve replacement may
induce shear stress at the periannular tis-
sue, patient-prosthesis mismatch per se can
be a cause of excessive intimal growth.
Another important issue in patients with
small aortic annuli is mechanical contact
between the ventricular septum and the
pivot guard of the prosthesis. It is conceiv-
able that the pivot guard protrudes to the
left ventricular side, which is unique to the
design of St Jude Medical valves,2 and thus
is readily in contact with the hypertrophied
ventricular septum. Recently, we carefully
examined patients with prosthetic valve
dysfunction in the aortic position with mul-
tidetector row computed tomography.3 In
that study, these pathognomic conditions
and pannus formation located mainly on
the pivot guard of the septal side were
confirmed. Therefore the possibility exists
that patients with small aortic annuli are
predisposed toward pannus formation re-
gardless of the absence of patient-prosthe-
sis mismatch, especially when the patient
has a small left ventricular outflow tract.
During the period of this study, 615
patients underwent aortic valve replace-
ment with St Jude Medical valves, and 265
e Journal of Thoracic and Cardiovascular Sof those were female (43%). Therefore, as
indicated by Dr Baciewicz, the female pro-
portion of patients who had prosthetic
valve dysfunction develop tended to be
higher than that of patients with normal
prosthetic valve function. A major reason
for this appears to be simply that female
patients had smaller aortic annulus diame-
ters. The mean age of our 7 female patients
who developed pannus formation was 62.6
 6.7 years, which did not differ from our
265 female patients with normally func-
tioning aortic valve prostheses. Although
the number of patients is small and our
results do not have statistical power, pa-
tient age per se may not be an important
factor in pannus formation.
In our study, 4 of 11 patients with pros-
thetic valve dysfunction had a short-term
history of warfarin withdrawal during treat-
ments for noncardiac disease (abdominal
operations and dental treatment). The re-
maining 7 patients received adequate anti-
coagulation therapy with warfarin through-
out the postoperative period. The
observations during reoperations and histo-
logic examinations of periannular tissue
did not demonstrate thrombus in all pa-
tients. These findings, however, do not ne-
gate the presence of perivalvular thrombus
at an earlier period of prosthetic valve dys-
function. Because pannus can develop as a
result of prosthetic valve thrombosis, inad-
equate anticoagulation also is considered to
be a risk factor for this disorder.
The cause of prosthetic valve dysfunc-
tion related to pannus may be multifacto-
rial, and definitive mechanisms for this dis-
order have not yet been conclusively
shown. On the basis of our findings that
excessive expression of transforming
growth factor  was observed in the pan-
nus, however, chronic inflammatory reac-
tion in the periannular lesions—perhaps as
a result of surgical trauma, reaction to the
foreign materials, mechanical contact, in-
adequate anticoagulation, and shear stress
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Prosthesis size and prosthesis-
patient size are unrelated to
prosthesis-patient mismatch
To the Editor:
We read with interest the report of Black-
stone and colleagues1 published in the Sep-
tember 2003 issue of the Journal, as well as
the editorial of Gillinov and coworkers2 in
the August 2003 issue. The implicit con-
clusion of these two articles was that pros-
thesis-patient mismatch (PPM) is a rare
occurrence after aortic valve replacement
and that it has a negligible impact with
regard to postoperative outcomes. To de-
fine PPM and analyze its consequences,
both sets of authors chose, however, to use
an indexed area based on the internal geo-
metric dimension of the prosthesis divided
by the patient’s body surface area, rather
than the indexed effective orifice area,
which is the physiologic parameter most
often used to define PPM. They justified
their choice of parameter on the basis that
geometric measures “are determined before
implantation, have much less variability,
and are independent of hemodynamic
state.”1
The physiologic and clinical relevance
of the indexed internal geometric area as
used by these authors must, however, be
challenged. Indeed, it has never been
shown that this parameter can be related, in
any significant manner, to transvalvular
pressure gradients; in particular, it has been
demonstrated that the indexed internal geo-
metric orifice area cannot be used to predict
which patients will have high postoperative
3gradients. Inherent to the pathophysiology
1852 The Journal of Thoracic and Cardiovof valve PPM is the concept that too small
a prosthesis in too large a patient will pro-
duce abnormally high gradients and thus
have potentially detrimental consequences
such as might occur with a native aortic
stenosis. Thus if the indexed internal geo-
metric area cannot be related to postoper-
ative gradients, we do not see how it can
logically be used to identify PPM or to
characterize its severity.
In contrast, and despite its inherent lim-
itations, the indexed effective orifice area is
the only parameter that has consistently
been shown to correlate with postoperative
gradients, as well as being highly predic-
tive of adverse outcomes.3-5 Indeed, when
the definition of PPM is based on this pa-
rameter, the phenomenon has been shown
to be highly prevalent (19%-70%, depend-
ing on series4,5) and to be associated with
less symptomatic improvement, worse he-
modynamics at rest and during exercise,
less regression of left ventricular hypertro-
phy, and more cardiac events after opera-
tion.4,5 A recent report from our own lab-
oratory has clearly shown that PPM has a
major impact on early mortality, particu-
larly in patients with poor left ventricular
function and that, in contrast to other risk
factors, it can easily be prevented by use of
a simple strategy at the time of operation.5
Such a strategy was recently used by Cas-
tro and associates6; as a result, the inci-
dence of moderate-severe PPM in their
population was only 2.5%, instead of the
17% that would have occurred had this
prospective strategy not been used,
whereas operative mortality remained low
(1%). Extrapolating these findings to the
total number of aortic valve replacements
being performed each year in North Amer-
ica, it is estimated that approximately 1000
operative deaths could potentially be
avoided through use of such a strategy.
In this context, the conclusion of these
two articles with regard to the prevalence
of PPM and its consequences cannot be
accepted at face value, because the param-
eter used to define PPM is not valid to
characterize postoperative hemodynam-
ics.3 To the contrary, we still believe in the
“value of concentrating on better hemody-
namic performance”1 and that research
aimed at properly identifying PPM, as well
as preventing it, can significantly contrib-
ute to improved outcomes after aortic valve
surgery.
ascular Surgery ● June 2004Jean G. Dumesnil, MD, FRCPC, FACC
Philippe Pibarot, DVM, PhD, FACC
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Reply to the Editor:
We have long respected the excellent and
prolific work of Dumesnil and Pibarot, so it
is not surprising that we referred to their
publications in our articles. However, they
are unhappy in part with the way we have
interpreted (or misinterpreted) their
work,1,2 and in part with the surgical rec-
ommendations we based on survival data
from our multicenter meta-analysis,1 which
differ from their own, which were based




We studied the relation of geometric pros-
thesis size to time-related survival with
nine sources of data and nearly 70,000 pa-
tient-years of follow-up among 13,258 pa-
tients who underwent aortic valve replace-
ment with mechanical prostheses, stent-
